février 2020

21st International Meeting: Integrated Management of Acute and Chronic Cardiovascular Diseases
Integrated Management of Acute and Chronic Cardiovascular Diseases
What’s new in treating cardiovascular diseases?

In the last week of January 2020, the Association for the Promotion of Research in Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) invited 100 healthcare professionals to the picturesque Alpine town of Innsbruck in Austria to attend the 21st International Meeting Integrated Management of Acute and Chronic Cardiovascular Diseases.

 

From Prevention to Intervention

 

The conference covered a broad spectrum within the field of cardiovascular disease management from prevention to intervention, while focusing specifically on the following topics:

  • Atrial Fibrillation
  • Acute Cardiovascular Care
  • Heart Failure
  • Interventional Cardiology
  • Structural Heart Disease

 

The four-day event was organized by Prim. Univ.-Prof. Kurt Huber from the Wilhelminenspital in Vienna, Austria together with Harald Darius (Germany) and two colleagues from the United States; Bernard Gersh and Chris Granger. Patrons of the conference included the European Platelet Academy (EPA) and the Acute Cardiovascular Care Association (ACCA), which is a branch of the European Society of Cardiology (ESC). Over 40 international and national experts presented and debated current clinical research data as part of master lectures, symposia and interactive clinical case discussions.

Lectures included among many other topics:

  • Controversies in Interventional Cardiology and Acute Cardiovascular Care
  • The Impact of Socioeconomic Status on CV Disease: Wealth is Health?
  • Perioperative Atrial Fibrillation: Transient and Benign or a Major Long-term Problem

Plus, a range of interesting real-world patient cases was also discussed on the last day of the event.

 

AMOMED‘s Offer for Cardiology and Intensive Care Medicine

 

AMOMED was one of the proud sponsors of this event. We also welcomed many of the selected attendees at our booth to answer questions and provide in-depth information about how our products, devised for critical and life-threatening situations, can support them in their work to achieve better clinical outcomes and save lives.

AMOMED offers medicinal products which can be used in cases of cardiac arrhythmia, myocardial infarction or sepsis. Learn more or register here to gain access to our AmoMED Academy for studies and product insights. You can also contact us at office@amomed.com or +43 1 545 01 130. We are happy to answer any questions you may have.